Skip to main content
Premium Trial:

Request an Annual Quote

Monash University Purchases GE Healthcare Protein Purification Platform

NEW YORK, March 29 (GenomeWeb News) - GE Healthcare said today that Monash University in Victoria, Australia, has purchased a GE Healthcare AKTAxpress parallel protein-purification workstation.

 

The purchase has been funded through an Australian Research Council Linkage Infrastructure Equipment and Facilities grant for an undisclosed amount. The grant was awarded to a cadre of professors from the University of Monash, University of Melbourne, and the Walter and Eliza Health Institute, GE said.

 

According to GE, the AKTAxpress system is sold with two or four modules per system. Monash purchased three complete four-module systems for a 12-module system -- the largest configuration of its kind in the world, GE said. The system enables production of as many as 48 proteins simultaneously.

 

The new workstation will be "closely linked" to Victoria's $180 million Australian Synchrotron facility, slated to open in 2007, GE said.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.